Copyright Reports & Markets. All rights reserved.

Global Recombinant Coagulation Factors Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Recombinant Coagulation Factors Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Recombinant Coagulation Factors Market Size Growth Rate by Product
      • 1.4.2 Recombinant Factor VIII
      • 1.4.3 Recombinant Factor IX
      • 1.4.4 Von Willebrand Factor
      • 1.4.5 Other
    • 1.5 Market by End User
      • 1.5.1 Global Recombinant Coagulation Factors Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Research Organizations
      • 1.5.5 Academic Institutes
      • 1.5.6 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Recombinant Coagulation Factors Market Size
      • 2.1.1 Global Recombinant Coagulation Factors Revenue 2014-2025
      • 2.1.2 Global Recombinant Coagulation Factors Sales 2014-2025
    • 2.2 Recombinant Coagulation Factors Growth Rate by Regions
      • 2.2.1 Global Recombinant Coagulation Factors Sales by Regions
      • 2.2.2 Global Recombinant Coagulation Factors Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Recombinant Coagulation Factors Sales by Manufacturers
      • 3.1.1 Recombinant Coagulation Factors Sales by Manufacturers
      • 3.1.2 Recombinant Coagulation Factors Sales Market Share by Manufacturers
      • 3.1.3 Global Recombinant Coagulation Factors Market Concentration Ratio (CR5 and HHI)
    • 3.2 Recombinant Coagulation Factors Revenue by Manufacturers
      • 3.2.1 Recombinant Coagulation Factors Revenue by Manufacturers (2014-2019)
      • 3.2.2 Recombinant Coagulation Factors Revenue Share by Manufacturers (2014-2019)
    • 3.3 Recombinant Coagulation Factors Price by Manufacturers
    • 3.4 Recombinant Coagulation Factors Manufacturing Base Distribution, Product Types
      • 3.4.1 Recombinant Coagulation Factors Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Recombinant Coagulation Factors Product Type
      • 3.4.3 Date of International Manufacturers Enter into Recombinant Coagulation Factors Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Recombinant Coagulation Factors Sales by Product
    • 4.2 Global Recombinant Coagulation Factors Revenue by Product
    • 4.3 Recombinant Coagulation Factors Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Recombinant Coagulation Factors Breakdown Data by End User

    6 North America

    • 6.1 North America Recombinant Coagulation Factors by Countries
      • 6.1.1 North America Recombinant Coagulation Factors Sales by Countries
      • 6.1.2 North America Recombinant Coagulation Factors Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Recombinant Coagulation Factors by Product
    • 6.3 North America Recombinant Coagulation Factors by End User

    7 Europe

    • 7.1 Europe Recombinant Coagulation Factors by Countries
      • 7.1.1 Europe Recombinant Coagulation Factors Sales by Countries
      • 7.1.2 Europe Recombinant Coagulation Factors Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Recombinant Coagulation Factors by Product
    • 7.3 Europe Recombinant Coagulation Factors by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Recombinant Coagulation Factors by Countries
      • 8.1.1 Asia Pacific Recombinant Coagulation Factors Sales by Countries
      • 8.1.2 Asia Pacific Recombinant Coagulation Factors Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Recombinant Coagulation Factors by Product
    • 8.3 Asia Pacific Recombinant Coagulation Factors by End User

    9 Central & South America

    • 9.1 Central & South America Recombinant Coagulation Factors by Countries
      • 9.1.1 Central & South America Recombinant Coagulation Factors Sales by Countries
      • 9.1.2 Central & South America Recombinant Coagulation Factors Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Recombinant Coagulation Factors by Product
    • 9.3 Central & South America Recombinant Coagulation Factors by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Recombinant Coagulation Factors by Countries
      • 10.1.1 Middle East and Africa Recombinant Coagulation Factors Sales by Countries
      • 10.1.2 Middle East and Africa Recombinant Coagulation Factors Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Recombinant Coagulation Factors by Product
    • 10.3 Middle East and Africa Recombinant Coagulation Factors by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Recombinant Coagulation Factors Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Novo Nordisk
      • 11.2.1 Novo Nordisk Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novo Nordisk Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novo Nordisk Recombinant Coagulation Factors Products Offered
      • 11.2.5 Novo Nordisk Recent Development
    • 11.3 Bayer
      • 11.3.1 Bayer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bayer Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bayer Recombinant Coagulation Factors Products Offered
      • 11.3.5 Bayer Recent Development
    • 11.4 Baxter International
      • 11.4.1 Baxter International Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Baxter International Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Baxter International Recombinant Coagulation Factors Products Offered
      • 11.4.5 Baxter International Recent Development
    • 11.5 Grifols International
      • 11.5.1 Grifols International Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Grifols International Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Grifols International Recombinant Coagulation Factors Products Offered
      • 11.5.5 Grifols International Recent Development
    • 11.6 CSL Ltd
      • 11.6.1 CSL Ltd Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 CSL Ltd Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 CSL Ltd Recombinant Coagulation Factors Products Offered
      • 11.6.5 CSL Ltd Recent Development
    • 11.7 Kedrion
      • 11.7.1 Kedrion Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Kedrion Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Kedrion Recombinant Coagulation Factors Products Offered
      • 11.7.5 Kedrion Recent Development
    • 11.8 Octapharma AG
      • 11.8.1 Octapharma AG Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Octapharma AG Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Octapharma AG Recombinant Coagulation Factors Products Offered
      • 11.8.5 Octapharma AG Recent Development
    • 11.9 Biogen Idec
      • 11.9.1 Biogen Idec Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Biogen Idec Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Biogen Idec Recombinant Coagulation Factors Products Offered
      • 11.9.5 Biogen Idec Recent Development
    • 11.10 Wyeth
      • 11.10.1 Wyeth Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Wyeth Recombinant Coagulation Factors Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Wyeth Recombinant Coagulation Factors Products Offered
      • 11.10.5 Wyeth Recent Development
    • 11.11 Emergent BioSolutions

    12 Future Forecast

    • 12.1 Recombinant Coagulation Factors Market Forecast by Regions
      • 12.1.1 Global Recombinant Coagulation Factors Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Recombinant Coagulation Factors Revenue Forecast by Regions 2019-2025
    • 12.2 Recombinant Coagulation Factors Market Forecast by Product
      • 12.2.1 Global Recombinant Coagulation Factors Sales Forecast by Product 2019-2025
      • 12.2.2 Global Recombinant Coagulation Factors Revenue Forecast by Product 2019-2025
    • 12.3 Recombinant Coagulation Factors Market Forecast by End User
    • 12.4 North America Recombinant Coagulation Factors Forecast
    • 12.5 Europe Recombinant Coagulation Factors Forecast
    • 12.6 Asia Pacific Recombinant Coagulation Factors Forecast
    • 12.7 Central & South America Recombinant Coagulation Factors Forecast
    • 12.8 Middle East and Africa Recombinant Coagulation Factors Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Recombinant Coagulation Factors Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Recombinant Coagulation Factors market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Recombinant Coagulation Factors market based on company, product type, end user and key regions.

      This report studies the global market size of Recombinant Coagulation Factors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Recombinant Coagulation Factors in these regions.
      This research report categorizes the global Recombinant Coagulation Factors market by top players/brands, region, type and end user. This report also studies the global Recombinant Coagulation Factors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer
      Novo Nordisk
      Bayer
      Baxter International
      Grifols International
      CSL Ltd
      Kedrion
      Octapharma AG
      Biogen Idec
      Wyeth
      Emergent BioSolutions

      Market size by Product
      Recombinant Factor VIII
      Recombinant Factor IX
      Von Willebrand Factor
      Other
      Market size by End User
      Hospitals
      Clinics
      Research Organizations
      Academic Institutes
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Recombinant Coagulation Factors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Recombinant Coagulation Factors market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Recombinant Coagulation Factors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Recombinant Coagulation Factors submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Recombinant Coagulation Factors are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Coagulation Factors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now